vs
Side-by-side financial comparison of DOMO, INC. (DOMO) and Nutex Health, Inc. (NUTX). Click either name above to swap in a different company.
Nutex Health, Inc. is the larger business by last-quarter revenue ($151.7M vs $79.4M, roughly 1.9× DOMO, INC.). Nutex Health, Inc. runs the higher net margin — 7.8% vs -13.1%, a 20.9% gap on every dollar of revenue. On growth, DOMO, INC. posted the faster year-over-year revenue change (-0.5% vs -41.1%). Nutex Health, Inc. produced more free cash flow last quarter ($69.0M vs $1.1M). Over the past eight quarters, Nutex Health, Inc.'s revenue compounded faster (50.0% CAGR vs -0.5%).
Domo, Inc. is an American cloud software company based in American Fork, Utah, United States. It specializes in artificial intelligence, business intelligence, and data visualization and is designed to provide real-time access to business data for decision makers across the company with minimal IT involvement. It is a Software-as-a-Service (SaaS) venture.
Nutex Health Inc. is an American for-profit health care company and operator of healthcare facilities headquartered in Houston, Texas.
DOMO vs NUTX — Head-to-Head
Income Statement — Q3 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $79.4M | $151.7M |
| Net Profit | $-10.4M | $11.8M |
| Gross Margin | 74.2% | 30.4% |
| Operating Margin | -8.7% | 20.4% |
| Net Margin | -13.1% | 7.8% |
| Revenue YoY | -0.5% | -41.1% |
| Net Profit YoY | 44.6% | -80.8% |
| EPS (diluted) | $-0.25 | $2.34 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $79.4M | $151.7M | ||
| Q3 25 | $79.7M | $267.8M | ||
| Q2 25 | $80.1M | $244.0M | ||
| Q1 25 | $78.8M | $211.8M | ||
| Q4 24 | $79.8M | $257.6M | ||
| Q3 24 | $78.4M | $78.8M | ||
| Q2 24 | $80.1M | $76.1M | ||
| Q1 24 | $80.2M | $67.5M |
| Q4 25 | $-10.4M | $11.8M | ||
| Q3 25 | $-22.9M | $55.4M | ||
| Q2 25 | $-18.1M | $-17.7M | ||
| Q1 25 | $-17.7M | $21.2M | ||
| Q4 24 | $-18.8M | $61.6M | ||
| Q3 24 | $-19.5M | $-8.8M | ||
| Q2 24 | $-26.0M | $-364.0K | ||
| Q1 24 | $-18.7M | $-364.0K |
| Q4 25 | 74.2% | 30.4% | ||
| Q3 25 | 74.8% | 57.8% | ||
| Q2 25 | 74.2% | 51.2% | ||
| Q1 25 | 74.4% | 55.9% | ||
| Q4 24 | 75.0% | 55.0% | ||
| Q3 24 | 74.3% | 27.8% | ||
| Q2 24 | 74.1% | 29.7% | ||
| Q1 24 | 76.3% | 15.1% |
| Q4 25 | -8.7% | 20.4% | ||
| Q3 25 | -9.1% | 48.7% | ||
| Q2 25 | -17.9% | 13.8% | ||
| Q1 25 | -15.6% | 38.1% | ||
| Q4 24 | -13.9% | 44.4% | ||
| Q3 24 | -18.5% | 12.3% | ||
| Q2 24 | -26.8% | 7.0% | ||
| Q1 24 | -16.6% | 2.1% |
| Q4 25 | -13.1% | 7.8% | ||
| Q3 25 | -28.8% | 20.7% | ||
| Q2 25 | -22.5% | -7.3% | ||
| Q1 25 | -22.4% | 10.0% | ||
| Q4 24 | -23.5% | 23.9% | ||
| Q3 24 | -24.9% | -11.2% | ||
| Q2 24 | -32.5% | -0.5% | ||
| Q1 24 | -23.3% | -0.5% |
| Q4 25 | $-0.25 | $2.34 | ||
| Q3 25 | $-0.56 | $7.76 | ||
| Q2 25 | $-0.45 | $-2.95 | ||
| Q1 25 | $-0.45 | $3.33 | ||
| Q4 24 | $-0.48 | $11.56 | ||
| Q3 24 | $-0.51 | $-1.72 | ||
| Q2 24 | $-0.69 | $-0.07 | ||
| Q1 24 | $-0.51 | $-0.08 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | — | $185.6M |
| Total DebtLower is stronger | $124.2M | — |
| Stockholders' EquityBook value | $-191.9M | $329.4M |
| Total Assets | $201.6M | $918.5M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $185.6M | ||
| Q3 25 | — | $166.0M | ||
| Q2 25 | $47.2M | $96.7M | ||
| Q1 25 | $45.3M | $84.7M | ||
| Q4 24 | — | $40.6M | ||
| Q3 24 | — | $46.9M | ||
| Q2 24 | $61.2M | $40.8M | ||
| Q1 24 | $60.9M | $30.0M |
| Q4 25 | $124.2M | — | ||
| Q3 25 | $121.9M | — | ||
| Q2 25 | $119.7M | — | ||
| Q1 25 | $117.7M | — | ||
| Q4 24 | $115.6M | — | ||
| Q3 24 | $115.2M | — | ||
| Q2 24 | $114.1M | — | ||
| Q1 24 | $113.5M | — |
| Q4 25 | $-191.9M | $329.4M | ||
| Q3 25 | $-191.5M | $317.2M | ||
| Q2 25 | $-178.7M | $235.3M | ||
| Q1 25 | $-177.2M | $176.9M | ||
| Q4 24 | $-171.2M | $132.4M | ||
| Q3 24 | $-166.4M | $60.4M | ||
| Q2 24 | $-163.5M | $62.7M | ||
| Q1 24 | $-153.5M | $63.0M |
| Q4 25 | $201.6M | $918.5M | ||
| Q3 25 | $195.7M | $964.5M | ||
| Q2 25 | $189.7M | $841.0M | ||
| Q1 25 | $214.3M | $761.9M | ||
| Q4 24 | $190.2M | $655.3M | ||
| Q3 24 | $197.8M | $438.5M | ||
| Q2 24 | $204.4M | $422.4M | ||
| Q1 24 | $225.7M | $404.3M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $3.4M | $70.4M |
| Free Cash FlowOCF − Capex | $1.1M | $69.0M |
| FCF MarginFCF / Revenue | 1.4% | 45.5% |
| Capex IntensityCapex / Revenue | 2.9% | 0.9% |
| Cash ConversionOCF / Net Profit | — | 5.95× |
| TTM Free Cash FlowTrailing 4 quarters | $9.9M | $245.6M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $3.4M | $70.4M | ||
| Q3 25 | $3.4M | $99.5M | ||
| Q2 25 | $4.0M | $27.3M | ||
| Q1 25 | $8.9M | $51.0M | ||
| Q4 24 | $-13.7M | $54.0K | ||
| Q3 24 | $-6.2M | $6.8M | ||
| Q2 24 | $1.9M | $13.3M | ||
| Q1 24 | $5.4M | $3.1M |
| Q4 25 | $1.1M | $69.0M | ||
| Q3 25 | $1.0M | $99.2M | ||
| Q2 25 | $1.0M | $26.5M | ||
| Q1 25 | $6.7M | $50.9M | ||
| Q4 24 | $-16.2M | $-341.0K | ||
| Q3 24 | $-8.4M | $6.2M | ||
| Q2 24 | $-625.0K | $12.7M | ||
| Q1 24 | $2.9M | $2.3M |
| Q4 25 | 1.4% | 45.5% | ||
| Q3 25 | 1.3% | 37.0% | ||
| Q2 25 | 1.3% | 10.9% | ||
| Q1 25 | 8.5% | 24.0% | ||
| Q4 24 | -20.3% | -0.1% | ||
| Q3 24 | -10.7% | 7.8% | ||
| Q2 24 | -0.8% | 16.7% | ||
| Q1 24 | 3.6% | 3.4% |
| Q4 25 | 2.9% | 0.9% | ||
| Q3 25 | 2.9% | 0.1% | ||
| Q2 25 | 3.7% | 0.3% | ||
| Q1 25 | 2.8% | 0.0% | ||
| Q4 24 | 3.2% | 0.2% | ||
| Q3 24 | 2.8% | 0.8% | ||
| Q2 24 | 3.2% | 0.7% | ||
| Q1 24 | 3.1% | 1.1% |
| Q4 25 | — | 5.95× | ||
| Q3 25 | — | 1.80× | ||
| Q2 25 | — | — | ||
| Q1 25 | — | 2.40× | ||
| Q4 24 | — | 0.00× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
DOMO
| Subscription | $71.9M | 91% |
| Professional Servicesand Other | $7.5M | 9% |
NUTX
| Hospital Division | $143.7M | 95% |
| Population Health Management Division | $8.0M | 5% |
